An interventional study of Pasta manufactured with traditional wheat varieties (Senatore Cappelli, Korasan) and Pasta manufactured with current wheat varieties (Claudio) in Diabetes Type 2, sponsored by Azienda Ospedaliero-Universitaria Careggi. Status unknown at 1 site in Italy. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-07-20.
Sponsored by Azienda Ospedaliero-Universitaria Careggi · Not applicable, Interventional, and Other
This randomized, cross-over study compares pasta produced with three different wheat varieties (Senatore Cappelli, Korasan, Claudio). Patients with type 2 diabetes with no pharmacological treatment will be randomized to three different sequences, and asked to eat a standard portion of pasta on three different occasions, four days apart. 3-hour post-prandial interstitial glucose profiles will be recorded using trans-cutaneous sensors.
9,359 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,318 are open to participants now.
This study's planned enrollment of 30 is below the median of 80 across 7,525 interventional studies indexed under Diabetes Mellitus, Type 2.
Browse Diabetes Mellitus, Type 2 studies →Azienda Ospedaliero-Universitaria Careggi is the lead sponsor of 75 studies on the registry; 22 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Pasta manufactured with traditional wheat varieties (Senatore Cappelli, Korasan)
Other: Pasta manufactured with traditional wheat varieties (Senatore Cappelli, Korasan)
Other: Pasta manufactured with current wheat varieties (Claudio)
A single meal composed of a portion of pasta (with standardized dressing) manufactured with different wheat varieties
A single meal composed of a portion of pasta (with standardized dressing) manufactured with different wheat varieties
60-min glucose
Glucose (interstitial monitoring) 60 min after beginning of meal
Time frame: 60 minutes
30-min glucose
Glucose (interstitial monitoring) 30 min after beginning of meal
Time frame: 30 minutes
90-min glucose
Glucose (interstitial monitoring) 90 min after beginning of meal
Time frame: 90 minutes
120-min glucose
Glucose (interstitial monitoring) 120 min after beginning of meal
Time frame: 120 minutes
150-min glucose
Glucose (interstitial monitoring) 150 min after beginning of meal
Time frame: 150 minutes
180-min glucose
Glucose (interstitial monitoring) 180 min after beginning of meal
Time frame: 180 minutes
Area Under the Curve (AUC) glucose 30 min
Area under glucose (interstitial monitoring) curve 30 min after beginning of meal
Time frame: 30 minutes
AUC glucose 60 min
Area under glucose (interstitial monitoring) curve 60 min after beginning of meal
Time frame: 60 minutes
AUC glucose 90 min
Area under glucose (interstitial monitoring) curve 90 min after beginning of meal
Time frame: 90 minutes
AUC glucose 120 min
Area under glucose (interstitial monitoring) curve 120 min after beginning of meal
Time frame: 120 minutes
AUC glucose 180 min
Area under glucose (interstitial monitoring) curve 180 min after beginning of meal
Time frame: 180 minutes
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Ospedaliero-Universitaria Careggi